| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total other income (expense), net | 57,184 | -557,833 | -25,590 | 910 |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | - | -2,462,870 | -2,305,090 |
| Net loss | -3,066,589 | -2,272,035 | -2,462,870 | -2,305,090 |
| Basic net loss per share | -1.96 | -3.1 | -0.38 | -0.51 |
| Diluted net loss per share | -1.96 | -3.1 | -0.38 | -0.51 |
| Weight-average shares outstanding, basic | 1,560,909 | 731,817 | 6,528,064 | 4,529,045 |
| Weight-average shares outstanding, diluted | 1,560,909 | 731,817 | 6,528,064 | 4,529,045 |
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)